KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Retained Earnings (2016 - 2025)

Gilead Sciences (GILD) has disclosed Retained Earnings for 17 consecutive years, with $39.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 70.45% year-over-year to $39.0 million, compared with a TTM value of $39.0 million through Dec 2025, down 70.45%, and an annual FY2025 reading of $39.0 million, down 70.45% over the prior year.
  • Retained Earnings was $39.0 million for Q4 2025 at Gilead Sciences, up from $36.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $16.3 billion in Q4 2023 and bottomed at -$20.0 million in Q1 2023.
  • Average Retained Earnings over 5 years is $6.1 billion, with a median of $115.0 million recorded in 2022.
  • The sharpest move saw Retained Earnings crashed 100.13% in 2023, then surged 53380.0% in 2024.
  • Year by year, Retained Earnings stood at $83.0 million in 2021, then surged by 18800.0% to $15.7 billion in 2022, then increased by 3.93% to $16.3 billion in 2023, then plummeted by 99.19% to $132.0 million in 2024, then crashed by 70.45% to $39.0 million in 2025.
  • Business Quant data shows Retained Earnings for GILD at $39.0 million in Q4 2025, $36.0 million in Q3 2025, and $11.3 billion in Q2 2025.